Federated Hermes, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Federated Hermes, Inc.
- $43 Billion
- Q4 2024
A detailed history of Federated Hermes, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 492,803 shares of HRMY stock, worth $16.8 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
492,803
Previous 542,079
9.09%
Holding current value
$16.8 Million
Previous $21.7 Million
21.7%
% of portfolio
0.04%
Previous 0.05%
Shares
12 transactions
Others Institutions Holding HRMY
# of Institutions
254Shares Held
46.6MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$226 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$199 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$162 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$77.9 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$54 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.02B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...